{"data":{"id":"us/42-cfr-413.230","jurisdiction":"us","citation":"42 CFR 413.230","heading":"Determining the per treatment payment amount.","body":"The per-treatment payment amount is the sum of:\n(a) The per treatment base rate established in § 413.220, adjusted for wages as described in § 413.231, and adjusted for facility-level and patient-level characteristics described in §§ 413.232, 413.233, and 413.235 of this part;\n(b) Any outlier payment under § 413.237;\n(c) Any training adjustment add-on under § 413.235(c);\n(d) Any transitional drug add-on payment adjustment under § 413.234(c);\n(e) Any transitional add-on payment adjustment for new and innovative equipment and supplies under § 413.236(d); and\n(f) Any add-on payment adjustment for new renal dialysis drugs or biological products in existing ESRD PPS functional categories after the payment period for the transitional drug add-on payment adjustment has ended, as described in § 413.234(c)(3) and (g).","path":["Title 42—Public Health","CHAPTER IV—CENTERS FOR MEDICARE \u0026 MEDICAID SERVICES, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER B—MEDICARE PROGRAM","PART 413—PRINCIPLES OF REASONABLE COST REIMBURSEMENT; PAYMENT FOR END-STAGE RENAL DISEASE SERVICES; PROSPECTIVELY DETERMINED PAYMENT RATES FOR SKILLED NURSING FACILITIES; PAYMENT FOR ACUTE KIDNEY INJURY DIALYSIS","Subpart H—Payment for End-Stage Renal Disease (ESRD) Services"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-42.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:26:11Z","sha256":"b0e748917f3eef99e57839cb71ad966d632e414a31f5a1e8fc969b47fe69fa0f","source_id":"us-cfr","stale":true,"prev":"us/42-cfr-413.220","next":"us/42-cfr-413.231"},"notice":"GroundRules: Original legal text. Not legal advice."}